Mixed methods process evaluation of my breathing matters, a digital intervention to support self-management of asthma by Greenwell, Kate et al.
                          Greenwell, K., Ainsworth, B., Bruton, A., Murray, E., Russell, D.,
Thomas, M., & Yardley, L. (2021). Mixed methods process evaluation
of my breathing matters, a digital intervention to support self-
management of asthma. npj Primary Care Respiratory Medicine, 31,
[35]. https://doi.org/10.1038/s41533-021-00248-6
Publisher's PDF, also known as Version of record
License (if available):
CC BY
Link to published version (if available):
10.1038/s41533-021-00248-6
Link to publication record in Explore Bristol Research
PDF-document
This is the final published version of the article (version of record). It first appeared online via Nature Research at
https://doi.org/10.1038/s41533-021-00248-6 . Please refer to any applicable terms of use of the publisher.
University of Bristol - Explore Bristol Research
General rights
This document is made available in accordance with publisher policies. Please cite only the
published version using the reference above. Full terms of use are available:
http://www.bristol.ac.uk/red/research-policy/pure/user-guides/ebr-terms/
ARTICLE OPEN
Mixed methods process evaluation of my breathing matters, a
digital intervention to support self-management of asthma
Kate Greenwell 1✉, Ben Ainsworth2,3, Anne Bruton 4, Elizabeth Murray5, Daniel Russell6, Mike Thomas 7 and Lucy Yardley1,8
This study aimed to explore user engagement with ‘My Breathing Matters’, a digital self-management intervention for asthma, and
identify factors that may influence engagement. In a mixed methods design, adults with asthma allocated to the intervention arm
of a feasibility trial (n= 44) participated in semi-structured interviews (n= 18) and a satisfaction questionnaire (n= 36) to explore
their views and experiences of the intervention. Usage data highlighted that key intervention content was delivered to most users.
The majority of questionnaire respondents (78%; n= 28) reported they would recommend the intervention to friends and family.
Interviewees expressed positive views of the intervention and experienced several benefits, mainly improved asthma control,
medication use, and breathing technique. Factors that may influence user engagement were identified, including perceptions of
asthma control, current self-management practices, and appeal of the target behaviours and behaviour change techniques.
Findings suggested My Breathing Matters was acceptable and engaging to participants, and it was used as intended.
npj Primary Care Respiratory Medicine           (2021) 31:35 ; https://doi.org/10.1038/s41533-021-00248-6
INTRODUCTION
Asthma is estimated to affect 358 million people worldwide1. In
the UK, 8 million people have been diagnosed with asthma2. The
goal of asthma management is optimal control of asthma
symptoms, to reduce the risk of exacerbations, and for individuals
to be able to lead a full and productive life3,4; however, this is not
always achieved5,6. Despite the availability of effective treatments,
asthma outcomes remain sub-optimal, resulting in many avoid-
able deaths, hospital admissions, quality of life impairment, and
societal costs5,7–9. Clinical guidelines recommend promoting self-
management through the provision of a personalised asthma
action plan, attendance at annual asthma reviews, and correct
inhaler technique use10. However, patient adherence to regular
preventer medication, such as inhaled corticosteroids, is often
low11, patients’ inhaler technique can be poor12, personal asthma
action plans are underused, and annual asthma reviews are
underattended6,8.
One potentially cost-effective method for promoting self-
management is through digital interventions, which offer
convenient 24-h access to relevant and personalised self-
management support. There is preliminary evidence that digital
interventions for asthma self-management can lead to improve-
ments in asthma control and quality of life, with no evidence of
harm13,14. However, there is currently a lack of robust evaluations
of digital interventions for adults with asthma.
My Breathing Matters is an internet-based self-management
intervention for asthma, which aims to improve the quality of life
of adults with asthma through improved pharmacological (e.g.,
supporting medication adherence) and non-pharmacological (e.g.,
breathing retraining, stress reduction) self-management15. Other
digital interventions for asthma focus on controlling asthma
through pharmacological management or self-monitoring of
physiological and behavioural data14,16. Unique to this
intervention was the integration of non-pharmacological self-
management, including breathing retraining17 and several pre-
viously evaluated interventions promoting healthy lifestyle
behaviours (smoking cessation18, physical activity19, weight
management20, and handwashing to prevent infections21). It
was developed using theory-based, evidence-based, and person-
based approaches to intervention development to maximise its
effectiveness, feasibility and acceptability15,22,23. Trial feasibility
outcomes (such as recruitment, retention, and randomisation) in
our randomised controlled feasibility trial (RCT) with 88 adults with
asthma showed that a definitive RCT is feasible24. In addition, we
observed consistent trends with improvements in asthma-related
patient-reported outcome measures, including quality of life and
asthma control. Before a definitive trial can be carried out, it is
important to ensure that the intervention is acceptable to its
target group and used as intended, to maximise its
effectiveness25.
To achieve this, we carried out a mixed methods process
evaluation of My Breathing Matters embedded within the
feasibility trial. Process evaluations can help support and refine
an intervention’s ‘programme theory’, which describes how an
intervention is expected to lead to its effects (mechanisms of
impact), the key intervention components, and how these interact
with contextual factors (e.g., population, setting)26,27. Users’
‘engagement’ with digital interventions has been hypothesised
to moderate the intervention’s influence on its mechanisms of
impact28. Engagement has been defined in terms of the extent to
which an intervention is used (e.g., amount, frequency), the user’s
subjective experience of the intervention, and engagement with
wider behavioural goals, such as behaviour change and self-
management28,29. Engagement is influenced by the digital
intervention itself (content and delivery) and the context in which
the intervention is used28. In asthma, there is a lack of research
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on potential factors influencing engagement with digital
interventions13.
We aimed to explore user engagement with My Breathing
Matters by examining how participants in the feasibility study
used the intervention, and exploring participants’ experiences of
the intervention. To refine our programme theory, we sought to
identify aspects of the intervention’s delivery and content, and
contextual factors (any external factors that might interact with
the intervention to produce variations in the outcome) that may
strengthen or impede users’ engagement with the intervention.
RESULTS
Participants
Intervention usage data were available for all 44 participants. The
My Breathing Matters Satisfaction Questionnaire was administered
to all 36 participants in the intervention group, who registered
with the intervention (eight participants were given a hyperlink to
the intervention, but did not register). Seventeen intervention
users and one non-user (n= 18; 41%) agreed to be interviewed.
Participants who did not take part either withdrew before their
interview was due (n= 4; 9%), could not be contacted by phone
or email after multiple attempts (n= 18; 41%) or were too busy
(n= 4; 9%). Table 1 provides the participants’ demographics.
How did participants in the feasibility trial use the
intervention?
Of the intervention participants, 81.8% (n= 36) logged into My
Breathing Matters at least once and between 1 and 25 times
(Median= 4; IQR= 8). Those using the intervention more than
once (n= 27) used it between 1.89 to 337.85 days (Median=
120.96; IQR= 148.23). Each session (total sessions= 231) lasted
between 0.01 and 58.81 min (Median= 4.69; IQR= 8.33). Of the 34
participants who reached the core intervention content, most
(73.5%; n= 25) looked at both the pharmacological and non-
pharmacological content and most (71%; n= 24) chose to look at
the non-pharmacological content first. Table 2 provides informa-
tion on number of participants using each intervention compo-
nent. The breathing retraining module was the most viewed
component and over half of participants signed-up to the
breathing retraining challenge tool. The other intervention tools
were used by less than a third of participants.
What were intervention participants’ experiences of the
intervention?
In the My Breathing Matters Satisfaction Questionnaire, 86.1% (n=
31) of the intervention users (n= 36) reported that My Breathing
Matters provided at least some benefit (Fig. 1) and 69.4% (n= 25)
reported that there were ‘no disadvantages at all’ (Fig. 2). A large
majority of survey respondents (77.8%; n= 28) reported that they
would recommend My Breathing Matters to friends and family if
they needed similar care and treatment (Fig. 3).
Content analysis of the free-text comments identified 14
benefits of using My Breathing Matters (n= 28; Table 3) and nine
disadvantages (n= 13; Table 4). Information provision (n= 12)
and provision of breathing retraining (n= 5) were the most
commonly cited benefits. A dislike of the intervention’s design
(n= 3) and that the intervention was not accessible on
smartphones and computer tablets (n= 3) were the most
commonly cited disadvantages.
Thematic analysis of the qualitative interviews identified four
themes, which are outlined alongside the codes in Supplementary
Table 1.
The first theme was ‘Benefits of My Breathing Matters’. Many
participants reported how they noticed changes in their asthma
symptoms since using My Breathing Matters, including reduced
coughing, chest tightness, and breathlessness; improved peak
flow; feeling more in control of their asthma; and fewer or no
asthma attacks.
I’m not coughing when I wake up in the
morning any more, or rarely. I’m not waking
up in the night feeling tight-chested and
that I can’t breathe properly. (P14, 31–40
years old, female, asthma 21–30 years)
This change was mainly attributed to the breathing retraining
and improved medication use. In contrast, some interview
participants said that they did not notice any changes to their
asthma since using the intervention.
Participants who used the 4-week medication challenge (see Table
5) explained how this component had helped them get into the
habit of using their preventer inhaler and use their inhalers correctly.
I haven’t been terribly good at using the
brown [preventer] inhaler. But I have pretty
much got into the habit now and I would put
that very much down to the website
reminders. (P4, 61–70 years old, male,
asthma 21–30 years).
Others reported how, since using My Breathing Matters, they
had not needed to use their reliever inhaler as often. This was
because they had not had any exacerbations, were using their
preventer inhaler as prescribed, or started to practice the
breathing techniques provided in the intervention when they
were having symptoms instead.
Sometimes, I forget, you know, and I think,
‘Oh actually, perhaps I should have taken it
[reliever inhaler]’, but then I think let’s do my
breathing techniques. Sometimes I haven’t
needed to take it…the website’s been good
for that. (P1, 41–50 years old, female, asthma
21–30 years)
One participant reported how the intervention reassured them
that it was acceptable to use their reliever when they need to
(rather than just tolerating symptoms), while another had been told
by a health professional that their asthma had improved to a point
that meant they no longer needed to use their preventer inhaler.
Many participants spoke about how My Breathing Matters
improved their breathing awareness, technique and posture.
I just feel that, sort of, before I used to
breathe a lot through my mouth… And I
find that, obviously, that now I’m breathing
K Greenwell et al.
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through my nose, my asthma’s not as bad…
I find that I’m not coughing as much. (P12,
21–30 years old, female, asthma < 5 years)
Interview participants reported how My Breathing Matters had
helped them to better identify, and deal with, asthma triggers
(e.g., air pollution); gave them breathing and relaxation techniques
to manage chest tightness and breathlessness; and prompted
them to engage in healthy lifestyle changes (e.g., physical activity,
healthy eating). A few participants explained how the intervention
could help them to decide whether to seek health professional
advice, and help them avoid unnecessary GP visits or burdening
their healthcare team.
A few participants mentioned that their understanding of
asthma and its treatment had improved. One participant learned
how she should have had an asthma action plan, which she had
printed and intended to take to her to asthma clinic.
It might have been useful if I’d had one of
these [an action plan] years ago. Then I
might have known what to do at the time [I
had an asthma attack]. So that was extre-
mely useful. (P8, 61–70 years old, female,
asthma 5–10 years).
The action plan also prompted another participant to have
conversations with their family about what they should do if he
had an exacerbation and could not explain this to them at the
time. On the other hand, some participants commented how they
already knew a lot of the information, felt there was nothing new
in the intervention, found some of the content repetitive, or
believed the advice was common sense.
Some participants explained how the breathing retraining and
stress management techniques helped them relax or stay calm, in
particular when they were feeling tight chested, panicking when
having an asthma attack, and for trying to get to sleep. A few
participants explained how My Breathing Matters could make
people think more positively about asthma, especially if you have
just been diagnosed.
I think maybe that’s what I’ve really gained
from it [My Breathing Matters], I’ve thought
about it [asthma] more and if you think
about problems or if you think about
different things then that’s a good thing to,
you know, you’re actively trying to improve
something about it and, yeah, so I’m
definitely thinking more positively. (P11,
41–50 years old, female, asthma 21–30 years)
Other benefits included addressing any asthma concerns you
might have (e.g., side effects of medication, symptoms); providing
reassurance that there are things that can help them cope; and
highlighting that people with asthma are not alone and that there
are other people with asthma or similar problems.
The second theme was ‘Views on the intervention content’.
Participants particularly valued the breathing retraining, with
many finding this the most helpful component. Most participants
liked the videos and found the techniques relatively easy to learn.
A few people found some of the techniques difficult to learn,
including slow breathing and controlled breath holding, with one
person preferring to have received the training in person. Another
participant did not understand why the breathing exercises were
beneficial and found the video irritating.
Some participants did not want to rely solely on their asthma
medication to manage their asthma and liked that My Breathing
Matters provided alternative management strategies, mainly the
breathing retraining.
Anything that helps you only take the
amount of medication you really need and
helps you to self-control asthma in some
way. And if My Breathing helps you to do
that, that’s got to be a good thing. (P2, 61–70
years old, female, asthma 11–20 years)
Now, after using the website, it’s made me
think about, well, what other things can I do
to help myself, so that I don’t have to rely on
Table 2. Numbers (and percentages) of participants who used each





one page of the
session n (%)
Participants who
used the main tool in
the session n (%)
Pharmacological content
Medication advice 21 (58.3%) n/a
4-week challenge 19 (52.8%) 10 (27.8%)a
Personal asthma
action plan
16 (44.4%) 6 (16.7%)b
Annual asthma review 16 (44.4%) 1 (2.8%)c
Non-pharmacological content
Breathing retraining 27 (79.4%) 20 (55.6%)d
Stress management 13 (36.1%) 6 (16.7%)e
Friends and family
support
10 (27.8%) 1 (2.8%)f
Lifestyle changes
Weight management 3 (8.3%) n/a
Physical activity 3 (8.3%) n/a
Handwashing 2 (7.7%) n/a
Smoking cessation 0 n/a
aSigning up to the 4-week challenge.
bViewed blank plan or made online plan.
cBooked an appointment with GP and recorded the appointment online.
dSigned-up to breathing retraining.
eUsed the stress management tools.
fEmailed someone a link to the Friends and Family module.
K Greenwell et al.
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my inhaler so much? (P12, 21–30 years old,
female, asthma <5 years)
In the 4-week medication challenge (see Table 5), participants
valued the email reminders, the advice about keeping their
inhalers somewhere accessible as a reminder, and the realisation
that it was benefiting them. The other intervention components
(action plan, annual asthma review, stress management, and
friends and family) were used to a lesser extent. Most participants
either had not yet used the component or found that these
components were not relevant to them. None of the interview
participants reported contacting the Asthma UK helpline when
asked about this.
The third theme was ‘Views on the intervention design’.
Participants expressed positive views on the intervention design
and found the content easy to understand. Some participants
liked that it was designed by an experienced team and that it was
associated with a national charity (Asthma UK), and felt that the
information was authentic and high quality. Generally, people
found the intervention easy to navigate. However, a few people
experienced navigation and technical difficulties, including
Table 3. Content analysis of free-text comments regarding benefits of using My Breathing Matters (n= 28).
Code Description Frequency
Information provision Intervention had improved awareness, improved or validated understanding about asthma and its
management. Participants liked the lifestyle advice and tips on management. The information in
the intervention was reliable and clear.
12
Provision of breathing retraining The breathing exercises were cited as a benefit of using the intervention. The intervention helped
them realise the benefits of the breathing exercises/correct breathing, learn correct breathing and
be more aware of their breathing.
5
Medication adherence The intervention helped people to build a medication habit, ‘take notice’ of medication, and made
them realise they should be using a preventer inhaler regularly.
3
Lifestyle changes The intervention provided lifestyle advice, including healthy eating, weight management, and
physical activity. Participants had lost weight and increased their physical activity since using the
intervention.
3
Reassurance The intervention reassured people that their asthma symptoms were normal, that they were doing
the right things to manage their asthma, and confirmed what they already knew.
3
Relaxation The intervention helped people to relax. Participants started doing the relaxation techniques and
they helped one participant get to sleep.
3
Access to information The intervention provides access to information quickly and easily. The intervention can be
accessed at home.
2
Control of asthma symptoms The intervention helped people to control their asthma symptoms or improved their lung function. 2
Motivation for asthma self-
management
The intervention makes people think more about their asthma and gives them to motivation to
manage their asthma.
2
Provision of action plan Being given access to an action plan/made aware of it. 2
Speaking to friends and family Two participants had discussed asthma and its management with family and friends. 2
Dealing with triggers The intervention helped one person deal with asthma triggers. 1
General health The intervention made one person think about their general health, as well as asthma. 1
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Fig. 1 Benefits of My Breathing Matters. Participant responses to single item on My Breathing Matters Satisfaction Questionnaire relating to
benefits of using My Breathing Matters.
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Table 4. Content analysis of free-text comments regarding disadvantages of using My Breathing Matters (n= 13).
Code Description Frequency
Disliked design Aspects of the design participants disliked, in particular the unlocking feature. 3
Not accessible on their device The intervention could not be accessed on phone or computer tablet. 3
Difficulties logging on Participants experienced difficulties logging on. 2
Too many or too little emails Participants received too many or not enough emails to keep engaged. 2
Annoying The intervention was annoying or slow. 1
Boring The intervention was short and became boring after a few months. 1
Lack of human contact The intervention did not provide one-to-one human contact to allow the participant’s
questions to be answered.
1
Patronising The intervention was patronising. 1
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Fig. 2 Disadvantages of My Breathing Matters. Participant responses to single item on My Breathing Matters Satisfaction Questionnaire




























Fig. 3 NHS Friends and Family Test. Participant responses to NHS friends and family test relating to how likely they would be to recommend
My Breathing Matters to friends and family if they needed similar care and treatment.
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logging on, following URLs in emails, and accessing the
intervention by phone or tablet, or on their workplace computer.
Participants expressed mixed views regarding the unlocking
feature of My Breathing Matters, whereby new content was made
available to users over time. Some liked this feature as it
structured their learning and stopped them from feeling over-
whelmed by too much information, but others found it frustrating
or did not understand the reasoning behind the feature.
I’d have been bombarded with it all if it was
too much at once, so it was quite nice it
came in sections slowly… it’s too much to
take in otherwise. (P1, 41–50 years old,
female, asthma 31–40 years)
I wanted to look through other bits that
weren’t enabled and then had to wait for
them… I think that probably would discou-
rage me from using it. (P4, 61–70 years old,
male, asthma 21–30 years)
Participants liked receiving regular emails with additional beha-
vioural content from My Breathing Matters because they reminded
them to take their medication and use the website, provided
encouragement and additional advice, and facilitated quick access
back to the website. A few people expressed negative views of the
emails, including finding the email content irritating or not useful, or
that it made them feel guilty for not using the website.
The forth theme was ‘Contextual factors influencing interven-
tion engagement’. Participants’ engagement with My Breathing
Matters was influenced by their perceptions of their asthma
control. Participants explained how they did not engage with the
intervention or specific components (e.g., the Asthma UK helpline,
action plan, or the medication section) because they did not think
their asthma was severe enough.
I possibly briefly looked at the sort of action
plan thing, but decided that, actually, I didn’t
think it was gonna be beneficial for me… I
just thought that probably my asthma wasn’t
severe enough that it was something that I
needed to do at that moment in time. (P12,
21–30 years old, female, asthma <5 years)
Likewise, participants explained that they were more likely to
use the intervention when their asthma symptoms were bad
(e.g., in the winter or during allergy season), and less likely to use
it when their asthma was well controlled. A few participants
explained how, most of the time, they simply ‘forgot’ or tried not
to ‘dwell’ on their asthma unless it was significantly restricting
their lives.
My asthma is fairly well controlled, I haven’t
needed to refer to the [My Breathing
Matters] site… I’m very much a kind of
person that, actually, I don’t dwell on, you
know, things that might inhibit you in life,
and just get on with life… You know, I’ve
had far more worse than asthma. (P15,
61–70 years old, female, asthma 31–40 years)
Table 5. Description of My Breathing Matters intervention components.
Target behaviour Description
Improved preventer medication adherence • Information about the benefits of medication use for prevention of asthma symptoms.
• Addressing ‘common concerns’ about asthma medication.
• A 4-week challenge (in which users were encouraged to engage in habitual optimal
preventer inhaler use) to help people develop positive medication habits.
Appropriate healthcare service use • Tools to create and store a Personal Asthma Action Plan and provide encouragement
for its use.
• Provide encouragement to attend an annual Asthma Review.
Engagement with breathing retraining • A breathing retraining programme17 to help control asthma symptoms, including
videos on how to improve your breathing technique.
Engagement with stress management • Provision of stress management techniques, including relaxation, and advice on stress
management (e.g., time management) and adaptive ways of thinking (e.g., thought
awareness, using positive thinking, talking through your worries), to reduce asthma-
related stress.
Send information to friends and family to encourage them
to engage in asthma management
• Ability to send friends and family a hyperlink to relevant information about asthma
treatment and symptoms.
Lifestyle changes • Access to previously developed lifestyle change programmes adapted for asthma,
including:
• StopAdvisor18 to support smoking cessation,
•Getting Active19 to increase physical activity adapted for asthma,
• POWeR20 to support weight management,
•Germ Defence21 to promote handwashing to prevent infections.
K Greenwell et al.
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On the other hand, two people were unlikely to use it if it their
asthma was bad, instead choosing to seek medical attention.
Some participants explained that they did not use certain
components because they did not consider them relevant. For
example, they already practiced the recommended behaviours
(e.g., taking medication, attending reviews, being more active),
were not stressed (relating to the stress management techniques),
or their family or friends already knew about asthma.
Participants explained how they thought My Breathing Matters
would be most useful at the beginning of their asthma journey,
once you have been diagnosed with asthma. Likewise, some
people who have had asthma for a long time reported it was less
useful. A few participants explained how they were not confident
with using computers or expressed a dislike towards them. The
non-user we interviewed was keen to use the intervention, but felt
he lacked the computer skills to log onto it. Other reported
reasons for low usage or not using certain components included
lack of time or being busy with other priorities (e.g., work, family);
and comorbidities that made some of the intervention behaviours
(physical activity, breathing exercises) challenging.
What factors may influence user engagement with My
Breathing Matters?
Across the qualitative findings, we identified several contextual
factors and aspects of the intervention’s content and delivery that
may influence user engagement with the intervention (Fig. 4).
Contextual factors were derived from the interview data (theme 4)
and included pre-existing beliefs (e.g., perceptions of asthma
control/asthma-related quality of life, beliefs about medication),
knowledge of asthma management and skills (e.g., confidence
with computers), current self-management practices, environ-
mental factors (current season, lack of time), and health status
(time since diagnosis, comorbidities). The interview data and
qualitative data from the My Breathing Matters Satisfaction
Questionnaire highlighted aspects of the intervention’s content
and delivery, that may influence engagement including appeal
and perceived ease of the target behaviours (e.g., breathing
retraining); appeal of the behaviour change techniques (e.g., email
reminders) and design (e.g., content released over time, instruc-
tional videos); novelty, relevance and clarity of the intervention
content; and ease of use (navigation and accessing the website).
Users reported both positive and negative aspects, and both are
summarised along with the perceived benefits of the intervention
(derived from theme 1 of the interview data and the qualitative
questionnaire data) in Fig. 4.
DISCUSSION
This mixed methods process evaluation study explored users’
engagement with My Breathing Matters, an internet-based self-
management intervention for asthma. Overall, engagement with
the intervention was high, it was used as intended, and people
with asthma expressed positive views of the intervention, its
components, and its design features; thus, demonstrating that it
was acceptable to participants. Users reported experiencing
several benefits of the intervention, mainly improved asthma
control, medication use, and breathing technique. These per-
ceived benefits were in line with the hypothesised intervention
mechanisms of impact and outcomes outlined in our original logic
model. Our study findings also extended our current programme
theory by identifying aspects of the intervention (content and
delivery), and contextual factors that may influence user engage-
ment with the intervention.
Despite our attempts to engage those who did not perceive
themselves as having active asthma and only recruiting those with
impaired asthma-related quality of life, users still questioned the
relevance of the intervention and its components, and did not
believe that their asthma was severe enough for the intervention.
This mirrors other studies that have demonstrated disparities
between perceived and objective measures of asthma control,
with patients overestimating how well their asthma was
controlled30,31. Notably, user engagement in this study was high
Before the intervention During the intervention After the intervention
Positive aspects of intervention Negative aspects of intervention















Confidence with, and dislike
of, computers




Helpful design features (e.g. email
prompts, instructional videos,
structured content)
Ease of navigation and easy to
understand
Perceived relevance of content
Difficulties navigating or accessing
intervention.
Annoying or frustrating content (e.g.
content being released over time)
Difficulties with breathing exercises





with triggers, lifestyle changes)
Improved understanding of
asthma and its treatment
More positive perceptions of
asthma







Fig. 4 Summary of the qualitative findings. Demonstrating the contextual factors and aspects of the intervention content and delivery that
may influence engagement with My Breathing Matters and the perceived benefits.
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despite such beliefs. This may be due to our use of ‘positive illness
contexts’ as a key intervention design feature (promoting health
rather than preventing illness). In this way, even when users
considered the intervention not specifically necessary for asthma
control, My Breathing Matters still provided self-management
support. Users reported several benefits of the intervention, and
our feasibility study observed trends with improvement across a
range of asthma outcomes24. This demonstrates that interventions
developed using theory-based, evidence-based, and person-based
approaches that target likely barriers to behaviour change can
lead to effective user engagement and positive outcomes among
individuals with different health beliefs, such as those in
heterogeneous chronic disease populations.
Uniquely, My Breathing Matters integrated breathing retraining
alongside established pharmacological self-management
approaches. Consistent with other qualitative evaluations of
breathing retraining32,33, users valued how the non-
pharmacological approaches in My Breathing Matters could help
reduce their reliance on medication, which is an important goal
for people with asthma34. Most participants were satisfied with the
online delivery of breathing retraining, with just a few users
finding the exercises difficult to learn and only one participant
reporting that they would have preferred to receive their training
face-to-face with a health professional; thus further demonstrating
the feasibility of delivering breathing retraining via an unguided
digital intervention. A trial of breathing retraining demonstrated
that face-to-face delivery was no more effective than DVD
delivery17.
In an attempt to maximise user engagement and ensure all core
content was accessed31, we implemented a design feature
whereby new content was made available to users over time.
Although this feature had been used successfully in other
interventions35 and some study participants found this feature
helpful, others found this feature frustrating and did not under-
stand the rationale behind it. It may be that by restricting users’
access to specific content, the intervention may have impaired
their sense of control and autonomy, which are important factors
for maximising engagement28. In future versions of the interven-
tion, it would be helpful to provide users with a strong rationale
for this feature (e.g., to encourage people to practice the
techniques they have already accessed before trying new
techniques), but allow users to unlock additional content
themselves if they wished to maximise user autonomy22,28 and
avoid disengaging active users.
One strength of this study was its mixed methods design. The
triangulation of questionnaire measures with qualitative inter-
views, and usage data enabled us to explore different aspects of
intervention engagement and to increase the credibility of the
research. Even though some questionnaires such as the My
Breathing Matters Satisfaction Questionnaire were not formally
validated, we could examine the extent to which the intervention
is used, and users’ subjective experiences of using the intervention
and enacting its target behaviours (e.g., breathing retraining). Due
to the limited sample size of the feasibility trial (n= 88), we were
not powered to do a more in-depth analysis of the usage data. A
fully powered RCT is needed to explore how process measures,
such as perceptions of asthma, pre-intervention levels of
medication adherence, and time since diagnosis, is associated
with user engagement and asthma outcomes. It would also be
worthwhile exploring how usage might change across the
seasons, given that some participants explained how they were
more likely to use the intervention during certain seasons, when
their asthma symptoms were worse. Although we endeavoured to
recruit participants across a broad demographic range, partici-
pants were generally older and white, and had high levels of
educational attainment. They were also recruited from a feasibly
trial sample, so are unlikely to be representative of the wider
asthma population36. A wider reach would avoid further worsen-
ing the digital divide and health inequalities. Moreover, the small
sample size of the feasibility study meant that we could not























of life in primary 








Persuasive/credible information & user stories on the health & emotional 
consequences of appropriate medication use; Instructions on correct inhaler 
technique; Information to address medication concerns and overcoming 
barriers to adherence; Goal-setting, action planning, and email reminders for 
using preventer medication. 
Appropriate healthcare service useb: 
Persuasive/credible information & user/GP stories on the health & emotional 
consequences of personal asthma action plans (PAAPs) & asthma reviews; 
PAAP for patients to complete; Reminders to book a GP appointment to 
create a PAAP & for an asthma review. 
Breathing retraining (BR) c: 
Persuasive/credible information on health & emotional consequences of BR; 
Instructions and video demonstration of BR technique and feedback on 
technique; Information on overcoming barriers to practice & habit formation; 
Goal setting, action planning and self-monitoring of BR practice; Email 
reminders for practicing BR. 
Cognitive behavioural stress  management c: 
Persuasive/credible information and user stories on health & emotional 
consequences of stress reduction; Instructions on how to perform stress 
reduction techniques; Action planning and email reminders for practicing 
stress reduction. 
Healthy behaviour changec: 
Persuasive/credible information about the health consequences of healthy 
behaviour change; Provide access to healthy behaviour change interventions. 
Patient engagement with interventiona: 
Persuasive/credible information & user stories on the health & emotional 
consequences of intervention; Information on the development team’s 
expertise; Self-monitoring of asthma quality of life & tailored feedback; 
Email reminders to use intervention. 
Social supporta: 
Persuasive/credible information & user stories on the health & emotional 
consequences of social support; Link to information about asthma 
management for family & friends; Information about support provided by 









Fig. 5 Logic Model of My Breathing Matters intervention. aUptake and engagement facilitation; bPharmacological support; cNon-
pharmacological support.
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purposively sample participants based on their usage and were,
therefore, only able to recruit one non-user. A larger sample size
would have allowed us to better target and capture the views of
non-users, and those who were less engaged with the interven-
tion. Interviews with the control group would have allowed us to
explore their experiences with usual care, in order to explore
which perceived benefits are unique to the intervention and not
from the feasibility trial itself. Interviews with those who declined
to take part in the trial would have also given us useful insights
into their reasons for this, and how user engagement might be
improved37.
Our findings demonstrated that My Breathing Matters is
acceptable and engaging to its target group, and the intervention
was delivered and worked as intended. The person-based
approach to intervention development was key to maximising
intervention engagement and acceptability for adults with
asthma. Along with the findings from the feasibility trial, the
current study supports the move towards a fully powered RCT,
including a mediation and moderation analysis, with only minor
modifications to the intervention content required. More broadly,
our findings highlight aspects of intervention content and delivery
(such as targeting key issues using person-based approaches,
providing non-pharmacological self-management approaches),
and contextual factors (such as perceptions of asthma control,
current self-management practices) that may influence user
engagement with digital asthma interventions. These should be
considered when implementing the intervention or when devel-
oping asthma behaviour change interventions.
METHODS
Design
A convergent mixed methods design was used for the process evaluation
in which qualitative and quantitative methods are implemented in the
same research phase and given equal weight, but the data is analysed
separately38. The process evaluation was embedded in a feasibility RCT of
My Breathing Matters. Trial participants were randomised into an
intervention group who were given access to My Breathing Matters or a
usual care group. Outcome measures were assessed at baseline, 3 months
and 12 months. Further details on the trial methods and feasibility
outcomes are available elsewhere24. Quantitative usage data were
collected to describe patterns of intervention usage over the 12-month
study period. The My Breathing Matters Satisfaction Questionnaire was
devised for this study and administered to intervention participants at 12-
month follow-up to assess their satisfaction with the intervention.
Qualitative interviews were carried out to explore intervention participants’
views and experiences of My Breathing Matters. Ethical approval was
granted by the University of Southampton and South Central—Berkshire
Research Ethics Committee (REC reference: 16/SC/0614). To increase the
transferability of the research, the COREQ checklist39 was used to guide
reporting of the qualitative research (Supplementary Table 2), and ensure a
rich description of the participants and the research process.
Intervention
My Breathing Matters was systematically developed using person-based,
evidence-based, and theory-based approaches, drawing upon primary
mixed methods research17,31,40, quantitative14 and qualitative41 systematic
reviews, and consultation with Public and Patient Involvement (PPI)
representatives and clinical and intervention development experts.
Following a person-based approach22, guiding principles were created,
including intervention design objectives and design features to address
key issues, needs, and behavioural challenges of the target population
identified in the evidence synthesis stage. One key behavioural issue that
emerged from the literature search conducted in the intervention
development phase is that some people with non-optimal asthma control
do not consider themselves as people with active asthma42–44. Therefore,
one intervention design objective was to specifically engage this group. To
do this, the intervention maintained a positive illness context throughout
(referring to ‘keeping breathing healthy’ rather than ‘preventing asthma
symptoms’), provided optional and flexible support only when needed,
and promoted the belief that impaired quality of life can be improved
(Supplementary Fig. 1). To target influences on asthma control that are not
often acknowledged, such as anxiety, stress and lifestyle (e.g., smoking,
obesity, and avoidance of physical activity), other design objectives aimed
to encourage users to engage in non-pharmacological (e.g., breathing
retraining, stress management, and lifestyle changes), as well as
pharmacological self-management, to improve asthma control (see Yardley
et al.15 for this process in more detail).
Theory-based behaviour analysis was used to identify the influences on
target behaviours and the intervention components that could address
these, and describe the intervention in terms of existing theory and
programme level theory. A logic model was created to illustrate the
hypothesised mechanisms of impact that explain how My Breathing
Matters is expected to lead to improvements in asthma-related quality of
life (Fig. 5). My Breathing Matters is hypothesised to improve asthma-
related quality of life through behavioural adherence (improved pharma-
cological and non-pharmacological management, engagement with the
intervention), improved physiological outcomes (asthma control, lung
function, and exacerbations), and improved psychological outcomes
(stress, mood, and enablement). Table 5 outlines the components of the
intervention in more detail.
An intervention prototype was developed and, consistent with a person-
based approach, the views and experiences of adults with asthma who
used the intervention were explored using iterative qualitative methods
(think aloud and retrospective semi-structured interviews), and the
intervention was modified in response to this feedback.
On each unique login, users were asked to complete a brief quality of life
assessment measuring activities, sleep, stress, illness, and reliever
medication use (Supplementary Fig. 2). Based on their answers, users
were signposted to relevant content. Content was not available all at once,
rather different content was ‘unlocked’ at various time points after the
user’s first visit to the website to encourage long-term engagement with
the intervention (Supplementary Fig. 3). The intervention is self-directed,
but the contact details for the Asthma UK helpline were given to provide
additional support if required. The intervention is available at
mybreathingmatters.co.uk.
Participants and recruitment
Participants were eligible for the feasibility trial if they were aged 18 years
or over, had physician-diagnosed asthma managed in primary care, had
received at least one anti-asthma medication prescription in the previous
year, and could use the Internet (self-judged). Anti-asthma medication
included all commonly used inhaled and oral preparations for asthma
treatment (both regular medication and as-required reliever preparations),
such as inhaled corticosteroids, long and short acting beta agonists and
leukotriene receptor antagonists. No patients were receiving injected
biological treatments or maintenance oral corticosteroids. Participants also
needed to have an impaired asthma-related health status at baseline,
defined as a Mini Asthma Quality of Life Questionnaire45 score of less than
5.5. Full trial inclusion and exclusion criteria are described elsewhere24.
Eligible participants were identified and invited to take part in the trial
by seven general practices from the Wessex, UK primary care research
network. After the 3-month follow-up, all intervention group participants
(n= 44) were approached by phone or email by a member of the study
team and were invited to take part in a qualitative interview, irrespective of
whether they used the intervention. Drawing on the guidelines on
information power in qualitative interview studies46, we aimed to recruit
approximately 20 participants to the interview study. This number was
deemed adequate given the study’s narrow aim (views on one
intervention), the small source population (n= 44), the specificity of the
experiences, knowledge and properties among the intervention trial
participants, and the likely high quality of dialogue from using an
experienced qualitative researcher. Informed consent was obtained for all
trial participants. Participants received a £10 shopping voucher for
submitting their follow-up questionnaires at 12 months. Interview
participants did not receive any additional incentives for taking part.
Data collection
Intervention usage was automatically collected by the LifeGuide software
(https://www.lifeguideonline.org), which was used to create and host the
intervention. Data were collected on the number and duration of logins,
date of last login, and pages visited. Participants were informed that they
could use the intervention as much or as little as they liked.
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The My Breathing Matters Satisfaction Questionnaire (Supplementary
Note 1) was administered by paper to those who registered with the
intervention at the 12-month follow-up appointment with a research
nurse. Better understanding of the potential benefits and burdens of
health interventions can help us to optimise these interventions and
improve their effectiveness47,48. To explore these two aspects, we devised
two items to assess benefits gained from using the intervention and
disadvantages of the intervention, and open questions allowed partici-
pants to report any benefits and disadvantages. These items were
developed in discussion with our multidisciplinary intervention develop-
ment team, consisting of experts in intervention development and
evaluation, behavioural science, and health economics. The one-item
NHS Friends and Family Test49 assessed how likely participants are to
recommend the intervention to friends and family, if they needed similar
care and treatment using a 5-point Likert scale ranging from ‘extremely
likely’ to ‘extremely unlikely’, with a ‘don’t know’ option. This tool is used
by NHS England to assess patient satisfaction across a wide range of
services.
For the qualitative interviews, a semi-structured interview schedule was
developed by experts in health psychology (KG, BA, and LY) and asthma
(MT, BA, and AB), and a PPI representative with asthma (DR). Interview
questions were designed to explore the key functions for process
evaluation outlined in the Medical Research Council process evaluation
guidelines50: implementation (what was delivered), mechanisms of impact,
and contextual factors. Specifically, the questions explored participants’
experiences of the intervention and its components, how they used the
intervention, their perceived advantages and disadvantages of the
intervention, times they were more and less likely to use the intervention,
and reasons for any non-usage (See Supplementary Note 2 for interview
schedule). Open-ended questions were used to ascertain the most
important issues or challenges for participants.
Interviews were carried out by telephone by KG (female health
psychologist and research fellow who was experienced in qualitative
research) who was not involved in intervention development, and did not
know the participants prior to the interviews. Participants were told that
the interviews aimed to explore their view and experiences to help
improve the research and intervention for future users. Interviews took
place between July 2017 and January 2018, lasted between 21–65min,
were audio-recorded, and transcribed verbatim.
Data analysis
The intervention usage data and the closed questions of the My Breathing
Matters Satisfaction Questionnaire were analysed using descriptive
statistics to describe patterns of intervention usage. Content analysis51
was carried out on the open question data to identify benefits and
disadvantages of using the intervention.
The qualitative interviews were analysed using inductive thematic
analysis51,52. Data analysis was assisted by QSR’s NVivo 11 qualitative data
analysis software (QSR International Pty Ltd., 2017). Analysis was informed
by guidelines for establishing trustworthiness in qualitative research53–56.
KG familiarised herself with the data through repeated reading of the
transcripts. Initial codes were generated that were grounded in the data
and a coding manual was developed that listed all codes and themes,
including descriptions and example quotes from the text. To increase the
credibility of the research, the final coding manual was discussed and
agreed with two other researchers (BA and LY) and the final interpretations
in the results section were reviewed and agreed by all authors, as well as
two PPI representatives. The constant comparison method57, a grounded
theory technique, was used to compare codes across different participants,
contexts, and situations. Disconfirming case analysis54 was used to actively
identify data that did not fit with the identified themes. These two
techniques were used to ensure the analysis was carried out with rigour
and to increase its credibility. Participant quotes were used in the final
write-up to illustrate the themes and pseudonyms used to refer to these
participants. Data saturation was considered reached because participants
in later interviews did not indicate any significant new benefits, concerns,
or barriers to engagement with My Breathing Matters.
Once the qualitative analysis was complete, we reviewed key findings
from the interviews and the My Breathing Matters Satisfaction Ques-
tionnaire to identify contextual factors, and aspects of the intervention’s
content and delivery that may have influenced user engagement with the
intervention.
Reporting summary
Further information on research design is available in the Nature Research
Reporting Summary linked to this article.
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